Investigation of the physical aspects of beta imaging probes using scintillating fibers and visible light photon counters

por MacDonald, L R, Tornai, M P, Levin, C S, Park, J, Atac, Muzaffer
Publicado 1995

PB2222: THE PROTECTIVE EFFECT OF THE SPLEEN IN SICKLE CELL PATIENTS. A COMPARATIVE STUDY BETWEEN PATIENTS WITH ASPLENIA AND HYPERSPLENISM.

por Peretz, S., Livshits, L., Pretorius, E., Makhro, A., Bogdanova, A., Gassmann, M., Koren, A., Levin, C.
Publicado 2022

Discriminer la COVID-19 et la dengue des autres maladies fébriles dans le contexte d’une co-épidémie en zone tropicale : développement et validation interne des scores COVIDENGUE...

por Levin, C., Andry, F., Bruneau, L., Joubert, A., Accot, F., Maillard, O., Bertolotti, A., Gérardin, P.
Publicado 2021

Analyse comparative des caractéristiques cliniques et épidémiologiques des patients infectés par le SARS-CoV-2 et par le virus de la dengue dans un centre hospitalo-universitaire u...

por Joubert, A., Gerardin, P., Levin, C., Accot, F., Koumar, Y., Legrand, F., Poubeau, P., Manaquin, R., Bertolotti, A., Andry, F.
Publicado 2020

5613260 A PHASE -- IIA-IIB, OPEN LABEL, SINGLE CENTER TRIAL TO STUDY SAFETY, TOLERABILITY AND EFFICACY OF MEMANTINE AS SUPPORTIVE LONG-TERM TREATMENT OF SICKLE CELL PATIENTS: TRIAL...

por Levin, C.L., Koren, A.K., Peretz, S.S.P., Livshits, L.L., Makhro, A.M., Bogdanova, A.B., Gassmann, M.G.
Publicado 2023

How can we evaluate the cost-effectiveness of health system strengthening? A typology and illustrations

por Hauck, K., Morton, A., Chalkidou, K., Chi, Y-Ling, Culyer, A., Levin, C., Meacock, R., Over, M., Thomas, R., Vassall, A., Verguet, S., Smith, P.C.
Publicado 2019

P835: GENETIC BACKGROUND AND CLINICAL CHARACTERISTICS OF CONGENITAL NEUTROPENIAS IN ISRAEL

por Steinberg-Shemer, O., Yeshareem, L., Noy-Lotan, S., Dgany, O., Krasnov, T., Berger Pinto, G., Bielorai, B., Kuperman, A. A., Laor, R., Mandel-Shorer, N., Ben Barak, A., Levin, C., Mahdi, A., Miskin, H., Revel-Vilk, S., Levin, D., Benish, M., Zuckerman, T., Wolach, O., Pazgal, I., Gilad, O., Goldberg, T., Yacobovich, J., Izraeli, S., Tamary, H.
Publicado 2022

P817: SYNDROMES PREDISPOSING TO LEUKEMIA ARE A MAJOR CAUSE OF INHERITED CYTOPENIAS IN CHILDREN

por Gilad, O., Dgany, O., Noy -Lotan, S., Krasnov, T., Yacobovich, J., Rabinowicz, R., Goldberg, T., Kuperman, A., Abu-Quider, A., Miskin, H., Kapelushnik, N., Mandel-Shorer, N., Shimony, S., Harlev, D., Ben-Ami, T., Adam, E., Levin, C., Aviner, S., Elhasid, R., Berger-Achituv, S., Chaitman-Yerushalmi, L., Kodman, Y., Oniashvilli, N., Hameiri- Grosman, M., Izraeli, S., Tamary, H., Steinberg-Shemer, O.
Publicado 2022

PB1938: 4WHIM: EVALUATING MAVORIXAFOR, AN ORAL CXCR4 ANTAGONIST, IN PATIENTS WITH WHIM SYNDROME VIA A GLOBAL PHASE 3, RANDOMIZED, PLACEBO-CONTROLLED TRIAL WITH OPEN-LABEL EXTENSION

por Dale, D. C., Alsina, L., Azar, A., Badolato, R., Bertrand, Y., Deya, A., Dickerson, K. E., Ezra, N., Hasle, H., Kang, H. J., Kiani-Alikhan, S., Kuijpers, T., Kulagin, A., Langguth, D., Levin, C., Neth, O., Peake, J., Rutten, C. E., Shcherbina, A., Tarrant, T. K., Vossen, M. G., Wysocki, C. A., Belschner, A., Cadavid, D., Hu, Y., Jiang, H., MacLeod, R., Tang, W., Tillinger, M., Donadieu, J.
Publicado 2022